Loading, please wait ...

News Analytics

Kymera Therapeutics Logo jpg?p=facebook.
CAMBRIDGE, Mass., July 15, 2019 /PRNewswire/ -- Kymera Therapeutics Inc., a biotechnology company advancing the field of targeted protein degradation to create breakthrough therapies for previously untreatable diseases, today announced key leadership transitions. Kymera Co-founder and CSO Nello Mainolfi, PhD, has been appointed President of the company as former President and CEO Laurent Audoly, PhD, has decided to pursue new entrepreneurial opportunities.

The Angle

Subject Matter

  • Business, economics, society 59.18%
    • Companies, industries, organizations 100.00%
  • Science and technology 40.82%

Emotional Reaction






Dimensions/Depth Chart

If you find a dimension intereseting, we recommend you pick up one or two facts that you find intriguing and place them into your memory. That way you will have 2nd degree information about the topic if it comes up in conversation.

Accordingly, you can do the same with others as well.